Cancer Immunity’s final issue includes original research articles that provide evidence of immunoediting and immunoescape in a melanoma patient governed by NY-ESO-1-specific immunological pressure; demonstration for the first time that a DNA vaccine encoding an altered PASD1 epitope can induce CTLs to target the natural peptide expressed by human tumor cells; an update to the Peptide Database; and more.
Latest publications include an article demonstrating safe combinations of ipilimumab with two chemotherapy regimens in treatment of advanced melanoma; and a review on NKG2D ligands as potential therapeutic targets.
Latest publications include reports on Tregs as prognostic factor in predicting favorable outcome in familial epithelial ovarian cancer; immunogenicity of necrotic versus apoptotic cells; and whether an antibody against the Cancer/Testis antigen NY-ESO-1 improves efficacy of chemotherapy.
Latest publications include reports on the expression of MAGE-A3 in colorectal cancer patients and a new cancer-orientated database for genes encoding cell surface proteins.
This special inaugural relaunch issue of Cancer Immunity is dedicated to the memory of Dr. Lloyd Old, the journal’s founding editor-in-chief. The issue features a collection of personal reflections by some of Dr. Old’s closest collaborators, who share their narratives on him and his work at different key periods throughout his scientific career. Also included » Continue Reading.